ARCHIVES

Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock.

This article is from The Cancer Letter archive.

Vol. 31 No. 10 | March 11, 2005

Download PDF Visit The Full Archive

Related Articles

Varmus Projects FY2011 As “Particularly Tight”

November 12, 2010

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

August 31, 2012

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009

Draft Report Outlines New Toxicological Test Criteria

November 24, 1995

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009

Facilities Survey: $2.5 Billion Will Be Required From 1986-1990, With NCI’s Share At $678 Million

April 12, 1985